Women typically have lower blood pressure than men, with the gap being largest in young adulthood and narrowing with age. Between ages 18 and 39, the average woman’s systolic blood pressure is about 110 mm Hg compared to 119 mm Hg in men, a meaningful 9-point difference. This gap isn’t random. It’s driven by hormones, differences in how the nervous system regulates blood vessel tone, and a blood pressure control system that operates fundamentally differently in female and male bodies.
How Big the Gap Is, and When It Closes
National health survey data from the CDC illustrates how the sex difference in blood pressure shifts across a lifetime:
- Ages 18 to 39: Women average 110/68 mm Hg; men average 119/70 mm Hg.
- Ages 40 to 59: Women average 122/74 mm Hg; men average 124/77 mm Hg.
- Ages 60 and older: Women average 139/68 mm Hg; men average 133/69 mm Hg.
The pattern is striking. Young women have substantially lower blood pressure, the gap nearly disappears in middle age, and then it reverses: women over 60 actually tend to have higher systolic readings than men the same age. That reversal is tightly linked to menopause and the loss of estrogen’s protective effects on blood vessels.
Estrogen Relaxes Blood Vessels
The single biggest reason for the blood pressure gap is estrogen. This hormone actively lowers blood pressure through several mechanisms, all centered on keeping blood vessels relaxed and flexible.
Estrogen boosts the production of nitric oxide, a molecule that signals blood vessel walls to relax and widen. It does this by increasing both the amount and the activity of the enzyme responsible for making nitric oxide in the cells lining your blood vessels. At the same time, estrogen reduces molecules that would otherwise break nitric oxide down, so more of it stays available to do its job. The net effect is that blood flows through wider, more relaxed vessels, which lowers the pressure inside them.
Beyond nitric oxide, estrogen promotes the release of other vessel-relaxing chemicals while suppressing vessel-constricting ones. It dials down the production of compounds like thromboxane A2 and endothelin-1, both of which cause blood vessel walls to tighten. This gives premenopausal women a built-in chemical environment that favors lower vascular resistance and, consequently, lower blood pressure.
Testosterone Pushes Pressure Higher
While estrogen relaxes blood vessels, testosterone tends to have the opposite effect. Androgen receptors are found throughout the vascular system, in both the smooth muscle cells that control vessel diameter and the endothelial cells lining vessel walls. Testosterone increases the activity of enzymes in a hormonal cascade (the renin-angiotensin system) that constricts blood vessels and promotes fluid retention, both of which raise blood pressure.
Testosterone also increases reactive oxygen species, molecules that degrade nitric oxide and reduce its ability to keep vessels relaxed. This effect is especially notable because it means testosterone doesn’t just fail to provide the protection estrogen offers; it actively works against it. In animal studies, testosterone exposure increases vessel-constricting receptor activity and promotes the structural changes in blood vessels associated with high blood pressure.
The Renin-Angiotensin System Works Differently by Sex
Your body has a built-in blood pressure regulation system called the renin-angiotensin system. It has two arms: one that raises blood pressure by constricting vessels and retaining sodium, and a protective counterpart that lowers blood pressure. Men and women use these two arms in very different proportions.
Men generally have higher activity on the pressure-raising side. Serum levels of ACE, the enzyme that produces the vessel-constricting hormone angiotensin II, are higher in men than in women. Testosterone further amplifies this by increasing ACE activity and boosting the number of receptors that respond to angiotensin II’s constricting signal.
Estrogen does the reverse. It consistently reduces ACE activity and lowers the expression of the receptors that angiotensin II binds to in blood vessels, kidneys, and the adrenal glands (which control aldosterone, a hormone that makes your kidneys hold onto sodium and water). At the same time, estrogen upregulates the protective arm of the system, increasing ACE2 activity. ACE2 converts angiotensin II into a different molecule that relaxes blood vessels and promotes sodium excretion. Young female rats, for instance, are protected from certain forms of high blood pressure specifically because estrogen boosts this protective kidney pathway. When estrogen is removed in animal models, blood pressure rises and these protective enzyme levels drop.
The Nervous System Controls Pressure Differently in Women
Blood pressure isn’t just about hormones and vessel chemistry. Your sympathetic nervous system, the “fight or flight” network, plays a major role by controlling how tightly blood vessels squeeze and how hard the heart pumps. Here, too, men and women differ in ways that matter.
Resting sympathetic nerve activity is lower in women than in men. In one study, women averaged 19 nerve bursts per minute compared to 25 in men. But what’s more interesting than the raw numbers is how the nervous system connects to blood pressure in each sex. In men, higher sympathetic nerve activity correlates directly with higher vascular resistance: more nerve firing means tighter blood vessels. There’s also a compensating relationship where men with high sympathetic activity tend to have lower cardiac output, preventing blood pressure from spiking.
In women, these relationships simply don’t exist. Sympathetic nerve activity showed no correlation with either vascular resistance or cardiac output. Women also have blunted responses to the chemical signals that cause vasoconstriction, likely because estrogen’s vasodilatory effects buffer the impact. This means that even when a woman’s sympathetic nervous system is active, her blood vessels are less responsive to the “squeeze tighter” signal. Men and women essentially rely on completely different integrated mechanisms to maintain normal blood pressure, and the female version produces lower numbers at baseline.
What Happens After Menopause
The blood pressure advantage women have doesn’t last forever. As estrogen levels decline during the menopausal transition (typically in a woman’s late 40s to early 50s), every protective mechanism described above starts to weaken. Nitric oxide production drops. The balance of the renin-angiotensin system shifts toward the pressure-raising arm. Blood vessels lose their estrogen-driven relaxation.
The consequences go beyond just blood pressure. Declining estrogen triggers a cascade of metabolic changes, including increased visceral fat, insulin resistance, and unfavorable cholesterol shifts, all of which compound cardiovascular risk. This is why women over 60 end up with higher average systolic blood pressure than men the same age. The protective gap doesn’t just close; it reverses.
The timeline and severity vary. Non-Hispanic Black and Hispanic women may experience reduced estrogen-related cardiovascular protection earlier, making them more vulnerable to hypertension at younger ages. Women who had pregnancy-related blood pressure complications like preeclampsia or gestational hypertension also carry a higher long-term risk. When early pregnancy blood pressure patterns are combined with a history of these complications, they can help predict hypertension risk up to 14 years later.
Why the Difference Matters
Understanding that women’s lower blood pressure comes from active biological protection, not just being “smaller” or having lower body mass, changes how you think about cardiovascular risk across a lifetime. For women in their 20s and 30s, the estrogen-driven advantage is real but temporary. A reading of 130/80 in a young woman is more concerning than the same reading in a young man, because it suggests something is already overriding those protective mechanisms. After menopause, women’s risk catches up to and surpasses men’s, which is why cardiovascular disease remains the leading cause of death in women despite their earlier advantage. The biology that protects younger women makes the post-menopausal shift all the more important to recognize.